These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 18520072
1. Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients. Naito T, Mino Y, Otsuka A, Ushiyama T, Ozono S, Kagawa Y, Kawakami J. Biol Pharm Bull; 2008 Jun; 31(6):1292-6. PubMed ID: 18520072 [Abstract] [Full Text] [Related]
2. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients. Mino Y, Naito T, Otsuka A, Ushiyama T, Ozono S, Kagawa Y, Kawakami J. Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248 [Abstract] [Full Text] [Related]
3. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Naito T, Shinno K, Maeda T, Kagawa Y, Hashimoto H, Otsuka A, Takayama T, Ushiyama T, Suzuki K, Ozono S. Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031 [Abstract] [Full Text] [Related]
4. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation. Mino Y, Naito T, Matsushita T, Otsuka A, Ushiyama T, Ozono S, Hishida A, Kagawa Y, Kawakami J. Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521 [Abstract] [Full Text] [Related]
5. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients. Naito T, Mino Y, Otsuka A, Ushiyama T, Ito T, Ozono S, Kagawa Y, Kawakami J. J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405 [Abstract] [Full Text] [Related]
6. Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase. Mino Y, Naito T, Otsuka A, Takayama T, Ozono S, Kagawa Y, Kawakami J. J Clin Pharm Ther; 2011 Apr; 36(2):217-24. PubMed ID: 21366651 [Abstract] [Full Text] [Related]
7. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. Morissette P, Albert C, Busque S, St-Louis G, Vinet B. Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897 [Abstract] [Full Text] [Related]
8. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients. Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH. Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil. Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M. Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937 [Abstract] [Full Text] [Related]
10. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients. de Winter BC, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RA. J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584 [Abstract] [Full Text] [Related]
11. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE. Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511 [Abstract] [Full Text] [Related]
12. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients. Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344 [Abstract] [Full Text] [Related]
13. Effect of cyclosporine on mycophenolic acid area under the concentration-time curve in pediatric kidney transplant recipients. Filler G, Lepage N, Delisle B, Mai I. Ther Drug Monit; 2001 Oct; 23(5):514-9. PubMed ID: 11591896 [Abstract] [Full Text] [Related]
14. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus. Tedesco-Silva H, Felipe CR, Slade A, Schmouder RL, Medina Pestana JO. Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696 [Abstract] [Full Text] [Related]
18. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients. Merkel U, Lindner S, Vollandt R, Sperschneider H, Balogh A. Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513 [Abstract] [Full Text] [Related]
19. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication. Brown NW, Aw MM, Mieli-Vergani G, Dhawan A, Tredger JM. Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. Filler G, Zimmering M, Mai I. Pediatr Nephrol; 2000 Feb; 14(2):100-4. PubMed ID: 10684356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]